Salarius Pharmaceuticals, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Salarius Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2023.
  • Salarius Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.42M, a 63.3% increase year-over-year.
  • Salarius Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$6.46M, a 78.5% increase year-over-year.
  • Salarius Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$12.5M, a 60.3% increase from 2022.
  • Salarius Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$31.6M, a 148% decline from 2021.
  • Salarius Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.8M, a 73.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$12.5M +$19.1M +60.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 -$31.6M -$18.8M -148% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 -$12.8M -$5.42M -73.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 -$7.35M -$416K -6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 -$6.94M -$5.27M -315% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 -$1.67M +$32.8M +95.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-23
2017 -$34.4M +$5.06M +12.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$39.5M -$10.4M -35.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-06
2015 -$29.1M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.